Navigation Links
LifeNet Health Announces First Bio-Implant with New Preservation Technology
Date:11/9/2009

VIRGINIA BEACH, Va., Nov. 9 /PRNewswire/ -- LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology

Preservon® is a new, proprietary glycerol-based preservation solution that allows allograft bio-implants to be stored in a fully hydrated state at ambient temperature. This eliminates the need to freeze or freeze-dry bio-implants, doing away with lengthy thawing and rehydration times in operating rooms. VG2C with Preservon® represents the first machined composite bio-implant allografts delivered to the operating room in a fully hydrated state without the need for frozen storage.

VG2C allograft bio-implants in frozen form have been one of the most widely utilized machined allografts for anterior cervical fusion surgery, with over 200,000 grafts distributed since 2002. This new ambient storage packaging provides greater convenience for the hospital and OR staff and eliminates the need for expensive freezer storage while retaining the proven performance that surgeons have grown to trust for their patients.

Preservon® combined with LifeNet Health's patented Allowash XG process delivers a sterile (SAL of 10(-6)) allograft bio-implant with the full mechanical properties associated with frozen grafts in an ambient storage package.

"This is a leading advancement in our field. Preservon® allograft bio-implants will save valuable OR time and preserve product integrity. It will benefit surgeons, hospitals and most importantly the patients whom we serve. This is part of our mission in saving lives and restoring health," said Rony Thomas, LifeNet Health CEO and President.

Preservon® is one of several process technology platforms that LifeNet Health has developed to enhance the utility and clinical effectiveness of human allograft tissue. LifeNet Health is currently evaluating other applications that can benefit from this break-through technology including skin, cartilage and other cardiovascular tissues.

Since 1995, LifeNet Health has distributed more than two million bio-implants with no incidence of disease transmission linked to tissue screened and processed using LifeNet Health's proprietary Allowash XG® technology. All allograft tissue undergoes a multi-step quality assurance review that exceeds the standards set by both the FDA and American Association of Tissue Banks (AATB).

About LifeNet Health

LifeNet Health, a non-profit global leader in regenerative medicine, is the world's largest provider of bio-implants and organs for transplantation whose mission is saving lives and restoring health by advancing the field of tissue engineering.

For additional information about LifeNet Health, visit www.lifenethealth.org.

SOURCE LifeNet Health


'/>"/>
SOURCE LifeNet Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
2. Recession Continues to Depress Sales at Allied Healthcare Products
3. McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP
4. Watson to Present at Credit Suisse Healthcare Conference
5. Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results
6. Statement of Americas Specialty Medicines Companies On House Health Care Bill (H.R. 3962)
7. OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy
8. Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
9. Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the Donut Hole
10. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
11. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):